TECHNOLOGY SUMMARY

Sensible’s Rapid PCR platform is designed to test patients for infectious diseases using PCR technology at the point-of-care. Sensible’s platform was developed based on pandemic-testing principles. Sensible’s platform can generate a fully-automated, real-time PCR result in 10 minutes for the same price as a rapid antigen test.

AREA/MATURITY/AWARDS

Primary Application Area: Medical Devices & Materials

Technology Development Status: Proven Manufacturability

Technology Readiness Level: TRL 7

SHOWCASE SUMMARY

Organization Type: Mid-stage Startup (A or B)

Website: http://www.sensibledx.com

MARKET KEYWORDS

Market Keywords: point-of-care, infectious disease, in-vitro diagnostics